{ event: "article_read", name: `SoliMix Study Results Summary`, author: ``, tags: `Diabetes | Diabetes | inspiration-and-innovation | cutting-edge-science`, publication_date: ``, interaction_type: "content" }
SoliMix Study Results Summary
Discover clinical outcomes with iGlarLixi versus Premix BIAsp 30 in the SoliMix Randomized Controlled Trial leading to advancing therapy in sub-optimally controlled basal insulin-treated Type-2 diabetes.
.jpg2/jcr:content/image%20(20).jpg)
Related articles
MAT-BH-2300623/v1/November2023